Erratum: Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor. - Eyre TA; Song Y; Hermine O; Shuang Y; Jurczak W; Farias JS; Mahuad C; Özcan M; Jachimowicz RD; Chen T; Ivanova E; Li X; et al. (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2026)